Cheng Zhiwen, Geng Haitao, Cheng Yufeng, Dong Ningxia, Ning Fangling, Yu Zeshun, Jian Jinbo, Chen Shaoshui
Department of Radiotherapy, Qilu Hospital of Shandong University, Jinan 250012, P.R. China.
J BUON. 2018 May-Jun;23(3):814-819.
To investigate the effects of microRNA-210 (miRNA- 210) on the biological behaviors (proliferation and invasion) of EC109 cells of highly metastatic human esophageal cancer (EC).
The EC109 genomic DNA of human EC was used as a template to amplify the precursor sequence of miRNA-210 by polymerase chain reaction (PCR). The precursor sequence of miRNA-210 was sub-cloned into the eukaryotic expression vector pcDNA3.1(-) via double digestion by BamH I and Hind III restriction enzymes. Then the pcDNA3.1 (-)-pri-miRNA-210 vector (named as p-miRNA-210) that was constructed successfully was transiently transfected into EC109 cells of human EC in vitro. Quantitative real-time PCR (qRT-PCR) was used to detect the expression level of mature miR-210. 3-(4,5-dimethyl-2-thiazolyl)-2,5- diphenyl-2-H-tetrazolium bromide (MTT) assay and scratch method were adopted to detect the proliferation and in vitro migration of EC109 cells, and flow cytometry was performed to detect the degree of cell apoptosis.
The eukaryotic expression vector carrying miRNA- 210 was constructed successfully. Compared with that in the blank group (Mock) and the control group (P-Blank), miRNA-210 was overexpressed in the transfected EC109 cells. The cell apoptosis was significantly increased compared with that in the control group (p<0.05); the inhibition of proliferation of EC109 cells in the p-miRNA-210 vector transfected group was remarkably elevated (p<0.05), and wound healing ability was also significantly increased (p<0.05).
The overexpression of miRNA-210 can significantly inhibit the proliferation of EC109 cells of human EC and accelerate the migration ability and the rate of apoptosis, providing a potential strategy for the treatment of EC.
探讨微小RNA-210(miRNA-210)对高转移性人食管癌(EC)EC109细胞生物学行为(增殖和侵袭)的影响。
以人食管癌EC109基因组DNA为模板,通过聚合酶链反应(PCR)扩增miRNA-210的前体序列。将miRNA-210的前体序列经BamH I和Hind III限制性内切酶双酶切后亚克隆至真核表达载体pcDNA3.1(-)。然后将成功构建的pcDNA3.1(-)-pri-miRNA-210载体(命名为p-miRNA-210)体外瞬时转染到人食管癌EC109细胞中。采用定量实时PCR(qRT-PCR)检测成熟miR-210的表达水平。采用3-(4,5-二甲基-2-噻唑基)-2,5-二苯基-2-H-四氮唑溴盐(MTT)法和划痕法检测EC109细胞的增殖和体外迁移能力,并通过流式细胞术检测细胞凋亡程度。
成功构建了携带miRNA-210的真核表达载体。与空白组(Mock)和对照组(P-Blank)相比,转染后的EC109细胞中miRNA-210过表达。与对照组相比,细胞凋亡显著增加(p<0.05);p-miRNA-210载体转染组中EC109细胞的增殖抑制明显升高(p<0.05),伤口愈合能力也显著增强(p<0.05)。
miRNA-210的过表达可显著抑制人食管癌EC109细胞的增殖,加速其迁移能力和凋亡率,为食管癌的治疗提供了一种潜在策略。